| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:52 UTC |
|---|
| Update Date | 2022-03-07 02:51:59 UTC |
|---|
| HMDB ID | HMDB0015464 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Yohimbine |
|---|
| Description | Yohimbine is only found in individuals that have used or taken this drug. It is a plant alkaloid with alpha-2-adrenergic blocking activity. Yohimbine has been used as a mydriatic and in the treatment of impotence. It is also alleged to be an aphrodisiac. [PubChem]Yohimbine is a pre-synaptic alpha 2-adrenergic blocking agent. The exact mechanism for its use in impotence has not been fully elucidated. However, yohimbine may exert its beneficial effect on erectile ability through blockade of central alpha 2-adrenergic receptors producing an increase in sympathetic drive secondary to an increase in norepinephrine release and in firing rate of cells in the brain noradrenergic nuclei. Yohimbine-mediated norepinephrine release at the level of the corporeal tissues may also be involved. In addition, beneficial effects may involve other neurotransmitters such as dopamine and serotonin and cholinergic receptors. |
|---|
| Structure | [H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2 InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (+)-Yohimbine | ChEBI | | (16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester | ChEBI | | 17alpha-Hydroxyyohimban-16alpha-carboxylic acid methyl ester | ChEBI | | Aphrodine | ChEBI | | Corynine | ChEBI | | Johimbin | ChEBI | | Quebrachin | ChEBI | | Quebrachine | ChEBI | | Yohimbic acid methyl ester | ChEBI | | Yohimbin | ChEBI | | (16a,17a)-17-Hydroxyyohimban-16-carboxylate methyl ester | Generator | | (16a,17a)-17-Hydroxyyohimban-16-carboxylic acid methyl ester | Generator | | (16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylate methyl ester | Generator | | (16Α,17α)-17-hydroxyyohimban-16-carboxylate methyl ester | Generator | | (16Α,17α)-17-hydroxyyohimban-16-carboxylic acid methyl ester | Generator | | 17a-Hydroxyyohimban-16a-carboxylate methyl ester | Generator | | 17a-Hydroxyyohimban-16a-carboxylic acid methyl ester | Generator | | 17alpha-Hydroxyyohimban-16alpha-carboxylate methyl ester | Generator | | 17Α-hydroxyyohimban-16α-carboxylate methyl ester | Generator | | 17Α-hydroxyyohimban-16α-carboxylic acid methyl ester | Generator | | Yohimbate methyl ester | Generator | | Aphrodyne | HMDB | | Aventis brand OF yohimbine hydrochloride | HMDB | | Solvay brand OF yohimbine hydrochloride | HMDB | | Yohimbine hydrochloride | HMDB | | Aphrodine hydrochloride | HMDB | | Hydrochloride, yohimbine | HMDB | | Pluriviron | HMDB | | Rauwolscine | HMDB | | Palisades brand OF yohimbine hydrochloride | HMDB | | Star brand OF yohimbine hydrochloride | HMDB | | StegroPharm brand OF yohimbine hydrochloride | HMDB | | Tartrate, corynanthine | HMDB | | Corynanthine | HMDB | | Corynanthine tartrate | HMDB | | Glenwood brand OF yohimbine hydrochloride | HMDB | | Hydrochloride, aphrodine | HMDB | | Kramer brand OF yohimbine hydrochloride | HMDB | | Rauhimbine | HMDB | | Yocon | HMDB | | Yohimbin spiegel | HMDB | | Yohimbine houdé | HMDB | | Yohimex | HMDB |
|
|---|
| Chemical Formula | C21H26N2O3 |
|---|
| Average Molecular Weight | 354.4427 |
|---|
| Monoisotopic Molecular Weight | 354.194342708 |
|---|
| IUPAC Name | methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8-tetraene-19-carboxylate |
|---|
| Traditional Name | yohimbine |
|---|
| CAS Registry Number | 146-48-5 |
|---|
| SMILES | [H][C@@]12CC[C@H](O)[C@H](C(=O)OC)[C@@]1([H])C[C@]1([H])N(CCC3=C1NC1=CC=CC=C31)C2 |
|---|
| InChI Identifier | InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1 |
|---|
| InChI Key | BLGXFZZNTVWLAY-SCYLSFHTSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as yohimbine alkaloids. These are alkaloids containing the pentacyclic yohimban skeleton. The Yohimbinoid alkaloids contain a carbocyclic ring E arising through C-17 to C-18 bond formation in a corynantheine precursor. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Yohimbine alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Yohimbine alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Yohimbine
- Corynanthean skeleton
- Yohimbine alkaloid
- Beta-carboline
- Pyridoindole
- 3-alkylindole
- Indole
- Indole or derivatives
- Aralkylamine
- Beta-hydroxy acid
- Hydroxy acid
- Benzenoid
- Piperidine
- Heteroaromatic compound
- Methyl ester
- Cyclic alcohol
- Pyrrole
- Amino acid or derivatives
- Tertiary aliphatic amine
- Carboxylic acid ester
- Tertiary amine
- Secondary alcohol
- Azacycle
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Organoheterocyclic compound
- Organic oxide
- Organonitrogen compound
- Organic nitrogen compound
- Organooxygen compound
- Amine
- Carbonyl group
- Organic oxygen compound
- Alcohol
- Organopnictogen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | - methyl 17-hydroxy-20xi-yohimban-16-carboxylate (CHEBI:10093 )
- Indole alkaloids (C09256 )
|
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 241 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.35 g/L | Not Available | | LogP | 2.73 | HANSCH,C ET AL. (1995) |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections| Adduct Type | Data Source | CCS Value (Å2) | Reference |
|---|
| [M+H]+ | CBM | 186.5 | 30932474 |
|
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.7 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.7344 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.64 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 53.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1832.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 198.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 166.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 168.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 141.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 404.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 400.7 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 479.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 770.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 406.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1312.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 248.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 277.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 358.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 209.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 87.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Yohimbine,1TMS,isomer #1 | COC(=O)[C@H]1[C@@H](O[Si](C)(C)C)CC[C@H]2CN3CCC4=C([NH]C5=CC=CC=C45)[C@@H]3C[C@@H]21 | 3300.1 | Semi standard non polar | 33892256 | | Yohimbine,1TMS,isomer #2 | COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C([C@@H]3C[C@@H]21)N([Si](C)(C)C)C1=CC=CC=C41 | 3221.8 | Semi standard non polar | 33892256 | | Yohimbine,2TMS,isomer #1 | COC(=O)[C@H]1[C@@H](O[Si](C)(C)C)CC[C@H]2CN3CCC4=C([C@@H]3C[C@@H]21)N([Si](C)(C)C)C1=CC=CC=C41 | 3188.4 | Semi standard non polar | 33892256 | | Yohimbine,2TMS,isomer #1 | COC(=O)[C@H]1[C@@H](O[Si](C)(C)C)CC[C@H]2CN3CCC4=C([C@@H]3C[C@@H]21)N([Si](C)(C)C)C1=CC=CC=C41 | 3093.1 | Standard non polar | 33892256 | | Yohimbine,2TMS,isomer #1 | COC(=O)[C@H]1[C@@H](O[Si](C)(C)C)CC[C@H]2CN3CCC4=C([C@@H]3C[C@@H]21)N([Si](C)(C)C)C1=CC=CC=C41 | 3943.2 | Standard polar | 33892256 | | Yohimbine,1TBDMS,isomer #1 | COC(=O)[C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@H]2CN3CCC4=C([NH]C5=CC=CC=C45)[C@@H]3C[C@@H]21 | 3496.1 | Semi standard non polar | 33892256 | | Yohimbine,1TBDMS,isomer #2 | COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCC4=C([C@@H]3C[C@@H]21)N([Si](C)(C)C(C)(C)C)C1=CC=CC=C41 | 3398.3 | Semi standard non polar | 33892256 | | Yohimbine,2TBDMS,isomer #1 | COC(=O)[C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@H]2CN3CCC4=C([C@@H]3C[C@@H]21)N([Si](C)(C)C(C)(C)C)C1=CC=CC=C41 | 3515.2 | Semi standard non polar | 33892256 | | Yohimbine,2TBDMS,isomer #1 | COC(=O)[C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@H]2CN3CCC4=C([C@@H]3C[C@@H]21)N([Si](C)(C)C(C)(C)C)C1=CC=CC=C41 | 3575.6 | Standard non polar | 33892256 | | Yohimbine,2TBDMS,isomer #1 | COC(=O)[C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)CC[C@H]2CN3CCC4=C([C@@H]3C[C@@H]21)N([Si](C)(C)C(C)(C)C)C1=CC=CC=C41 | 4053.9 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Yohimbine GC-MS (Non-derivatized) - 70eV, Positive | splash10-008i-0396000000-43448cca1e1ad4343ac0 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Yohimbine GC-MS (1 TMS) - 70eV, Positive | splash10-00xs-2139200000-8288a21cfcdae82fc694 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Yohimbine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Yohimbine , positive-QTOF | splash10-0006-3921000000-e28dd8692e2b8dd63330 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Yohimbine 10V, Positive-QTOF | splash10-0a4r-0019000000-98fd50566f845231fbed | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Yohimbine 20V, Positive-QTOF | splash10-0a4r-0129000000-49a3b77851cb2f327e51 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Yohimbine 40V, Positive-QTOF | splash10-0ffx-0891000000-1297a98bf2d980f32361 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Yohimbine 10V, Negative-QTOF | splash10-0udi-0009000000-6448f2e7be3b7fa35128 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Yohimbine 20V, Negative-QTOF | splash10-0udi-0009000000-a436855e9ddc5d8e061e | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Yohimbine 40V, Negative-QTOF | splash10-07ef-3956000000-386e3fa9fb16f1a30cf6 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Yohimbine 10V, Positive-QTOF | splash10-0a4i-0009000000-b3d998cb3c47c9700660 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Yohimbine 20V, Positive-QTOF | splash10-0a4i-0009000000-42b2cee0514145bdbc16 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Yohimbine 40V, Positive-QTOF | splash10-002g-0695000000-7eacdb4b3fbff0521dcd | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Yohimbine 10V, Negative-QTOF | splash10-0udi-0009000000-1bc1d16b561be98b6dbc | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Yohimbine 20V, Negative-QTOF | splash10-004i-0095000000-d9723526ae361fda41c5 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Yohimbine 40V, Negative-QTOF | splash10-0f96-0192000000-a13fb9eefdc725558673 | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|